Michael Gorelik, MD

Assistant Professor

  • Division of Otolaryngology

gorelik@surgery.wisc.edu
608-262-7181

K4/763
600 Highland Ave
Madison, WI 53792

Education

  • MS, Johns Hopkins University, Biotechnology, 2010
  • MD, Tufts University School of Medicine, 2015
  • Resident, University of Ilinois Chicago, Otolaryngology, 2020
  • Fellowship, Ann & Robert H. Lurie Children's Hospital of Chicago, Pediatric Otolaryngology, 2021

Clinical Specialties

Dr. Gorelik specializes in pediatric otolaryngology with a focus on complex pediatric airway and aerodigestive problems, management of congenital and malignant head and neck lesions, and hearing loss.

Dr. Gorelik’s expertise includes excision of thyroglossal duct cysts, branchial cleft anomalies, submandibular gland removal, parotidectomy, thyroidectomy, neck dissection, and management of lymphovascular malformations.

He treats the entire spectrum of airway and sleep related problems. He performs the following procedures: adenotonsillectomy, refractory sleep surgery, tongue base suspension, supraglottoplasty, epiglottopexy, endoscopic and open laryngotracheal reconstruction, slide tracheoplasty and tracheal resection.

Dr. Gorelik provides a wide range of services including Septoplasty, Sinus Surgery, Airway Dilation, Laser Procedures, Tracheostomy, Tracheal Resection, Parotidectomy, Thyroidectomy, Placement of Myringotomy and Tympanostomy Tube, Tympanoplasty, Endoscopic Ear Surgery, Mastoidectomy.

Research Interests

Dr. Gorelik’s interests include laryngotracheal reconstruction, novel treatment of laryngeal edema, device development, and surgical education.

Recent Publications

  • Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.
    Saini H, Rifkin R, Gorelik M, Huang H, Ferguson Z, Jones MV, Levy M
    BMC Neurol 2013 Aug 08; 13: 104
    [PubMed ID: 23927715]

  • Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor.
    Gorelik M, Orukari I, Wang J, Galpoththawela S, Kim H, Levy M, Gilad AA, Bar-Shir A, Kerr DA, Levchenko A, Bulte JW, Walczak P
    Radiology 2012 Oct; 265(1): 175-85
    [PubMed ID: 22923719]

  • Noninvasive monitoring of immunosuppressive drug efficacy to prevent rejection of intracerebral glial precursor allografts.
    Gorelik M, Janowski M, Galpoththawela C, Rifkin R, Levy M, Lukomska B, Kerr DA, Bulte JW, Walczak P
    Cell Transplant 2012; 21(10): 2149-57
    [PubMed ID: 22508097]

  • CEST phase mapping using a length and offset varied saturation (LOVARS) scheme.
    Song X, Gilad AA, Joel S, Liu G, Bar-Shir A, Liang Y, Gorelik M, Pekar JJ, van Zijl PC, Bulte JW, McMahon MT
    Magn Reson Med 2012 Oct; 68(4): 1074-86
    [PubMed ID: 22246684]

  • Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination.
    Walczak P, All AH, Rumpal N, Gorelik M, Kim H, Maybhate A, Agrawal G, Campanelli JT, Gilad AA, Kerr DA, Bulte JW
    Glia 2011 Mar; 59(3): 499-510
    [PubMed ID: 21264955]

All Publications on PubMed